Rua Bioscience Limited — Share Issue/Capital Change 2020

Nov 13, 2020

==> picture [101 x 49] intentionally omitted <==

Section 1: IssueName of issuer
	Section 1: Issue	r information
	Name of issuer		Rua Bioscience Limited
	NZX ticker code		RUA
	Class of financia	l product	Ordinary shares
	ISIN (If unknown	, check on NZX website)	NZRUAE0004S1
	Currency		NZD
	Section 2: Capital change details
	Number issued		250,366
	Nominal value (if any)		Not applicable
	Issue price per security		Not applicable
	Nature of the payment (for example, cash or otherconsideration)		Services provided by thoseemployees and executivedirector who participated in theemployee share bonus offer.
	Amount paid up (if not in full)		Not applicable
	Percentage of total class of Financial Products issued(calculated on the number of Financial Products of the Class,excluding any Treasury Stock, in existence)1		0.179%
	For an issue of Convertible Financial Products or Options, theprincipal terms of Conversion (for example the Conversionprice and Conversion date and the ranking of the FinancialProduct in relation to other Classes of Financial Product) or theOption (for example, the exercise price and exercise date)		Not applicable
	Reason for issue and specific authority for issue (the reasonfor change must be identified here)		Issue of ordinary shares tothose employees andexecutive director whoparticipated in the employeeshare bonus offer.
	Total number of Financial Products of the Class after the issue(excluding Treasury Stock) and the total number of FinancialProducts of the Class held as Treasury Stock after the issue.		140,262,591
	In the case of an acquisition of shares, whether those sharesare to be held as treasury stock		Not applicable
	Specific authority for the issue, acquisition, or redemption,including a reference to the rule pursuant to which the issue,acquisition, or redemption is made		Board resolutions dated 12November 2020. The ordinaryshares were issued inaccordance with Listing Rule4.6.

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (forexample: restrictions, escrow arrangements)	The ordinary shares will rankequally in all respects withexisting ordinary shares in RuaBioscience Limited at the dateon which they were issued.
Date of issue2	13 November 2020
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Rob Mitchell, Chief ExecutiveOfficer of Rua BioscienceLimited
Contact person for this announcement	Kerry Donovan
Contact phone number	+64 9 309 5840
Contact email address	Kerry.donovan@ruabio.com
Date of release through MAP	13 November 2020

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).